ResMed Inc.
MX ˙ BMV ˙ US7611521078
SecurityMX:RMD / ResMed Inc.
InstitutionBridgewater Associates, LP
ManagerRay Dalio, Bob Prince
Latest Disclosed Ownership39,237 shares
Latest Disclosed Value $ 8,807,922
Bridgewater Associates, LP reports 19.17% increase in ownership of RMD / ResMed Inc.

On May 15, 2026 - Bridgewater Associates, LP filed a 13F-HR form disclosing ownership of 39,237 shares of ResMed Inc. (MX:RMD) valued at $8,807,922 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 13, 2026 disclosing 32,924 shares of ResMed Inc.. This represents a change in shares of 19.17% during the quarter.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-15 2026-03-31 13F RESMED COM 761152107 39,237 6,313 19.17 8,808 11.06 0.0393
2026-02-13 2025-12-31 13F RESMED COM 761152107 32,924 942 2.95 7,930 -9.41 0.0289
2025-11-13 2025-09-30 13F RESMED COM 761152107 31,982 26,728 508.72 8,754 546.05 0.0343
2025-08-13 2025-06-30 13F RESMED COM 761152107 5,254 -114,077 -95.60 1,356 -94.93 0.0055
2025-05-14 2025-03-31 13F RESMED COM 761152107 119,331 32,060 36.74 26,712 33.84 0.1239
2025-02-13 2024-12-31 13F RESMED COM 761152107 87,271 -6,626 -7.06 19,958 -12.93 0.0915
2024-11-13 2024-09-30 13F RESMED COM 761152107 93,897 -72,216 -43.47 22,922 -27.91 0.1298
2024-08-14 2024-06-30 13F RESMED COM 761152107 166,113 17,407 11.71 31,797 7.98 0.1660
2024-05-14 2024-03-31 13F RESMED COM 761152107 148,706 -9,820 -6.19 29,448 7.99 0.1489
2024-02-14 2023-12-31 13F RESMED COM 761152107 158,526 -71,997 -31.23 27,270 -20.00 0.1526
2023-11-13 2023-09-30 13F RESMED COM 761152107 230,523 58,199 33.77 34,087 -9.47 0.2060
2023-08-11 2023-06-30 13F RESMED COM 761152107 172,324 -20,537 -10.65 37,653 -10.85 0.2325
2023-05-12 2023-03-31 13F RESMED COM 761152107 192,861 -20,312 -9.53 42,235 -4.81 0.2577
2023-02-13 2022-12-31 13F RESMED COM 761152107 213,173 -53,593 -20.09 44,368 -23.81 0.2422
2022-11-10 2022-09-30 13F RESMED COM 761152107 266,766 23,845 9.82 58,235 14.36 0.2948
2022-08-11 2022-06-30 13F RESMED COM 761152107 242,921 -27,869 -10.29 50,924 -22.45 0.2158
2022-05-13 2022-03-31 13F RESMED COM 761152107 270,790 83,388 44.50 65,669 34.53 0.2647
2022-02-14 2021-12-31 13F RESMED COM 761152107 187,402 26,053 16.15 48,814 14.79 0.2838
2021-11-12 2021-09-30 13F RESMED COM 761152107 161,349 -3,466 -2.10 42,524 4.66 0.2328
2021-08-13 2021-06-30 13F RESMED COM 761152107 164,815 75,028 83.56 40,630 133.24 0.2607
2021-05-14 2021-03-31 13F RESMED COM 761152107 89,787 15,508 20.88 17,420 10.33 0.1536
2021-02-12 2020-12-31 13F RESMED COM 761152107 74,279 37,854 103.92 15,789 152.87 0.1366
2020-11-13 2020-09-30 13F RESMED COM 761152107 36,425 36,425 -50.96 6,244 -60.45 0.0751
2020-08-12 2020-06-30 13F RESMED COM 761152107 0 -3,371 -100.00 0 -100.00
2020-05-14 2020-03-31 13F RESMED COM 761152107 3,371 3,371 497 0.0099
2019-05-14 2019-03-31 13F RESMED COM 761152107 0 -8,119 -100.00 0 -100.00
2019-02-13 2018-12-31 13F RESMED COM 761152107 8,119 8,119 925 0.0085
2018-11-13 2018-09-30 13F RESMED COM 761152107 0 -5,565 -100.00 0 -100.00
2018-08-13 2018-06-30 13F RESMED COM 761152107 5,565 -4,067 -42.22 576 -39.24 0.0058
2018-05-15 2018-03-31 13F RESMED COM 761152107 9,632 9,632 948 0.0090
2016-08-10 2016-06-30 13F RESMED COM 761152107 0 -49,576 -100.00 0 -100.00
2016-05-13 2016-03-31 13F RESMED COM 761152107 49,576 49,576 0.00 2,866 0.0363
2016-02-11 2015-12-31 13F RESMED COM 761152107 0 -13,788 -100.00 0 -100.00
2015-11-12 2015-09-30 13F RESMED COM 761152107 13,788 7,800 130.26 703 107.99 0.0094
2015-08-11 2015-06-30 13F RESMED COM 761152107 5,988 5,988 338 0.0031
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.